Gestational trophoblastic disease: Does central nervous system chemoprophylaxis have a role?

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1270-1272

  Gillespie, A M ^a   Siddiqui, N ^b   Coleman, R E ^a   Hancock, B W ^a  

^a Cancer Research Centre   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TROPHOBLASTIC DISEASE;

ADOLESCENT; ADULT; ANTIDOTES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DACTINOMYCIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; LUNG NEOPLASMS; METHOTREXATE; MIDDLE AGED; PATIENT COMPLIANCE; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 0032983936     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690203     Document Type: Article

References (14)

1. Althanassiou A, Newlands ES, Rustin GJS, et al (1983) Central nervous system metastases of choriocarcinoma: 23 years experience at Charing Cross Hospital. Cancer 52: 1728-1735
2. Bagshawe KD and Harland S (1976) Immunodiagnosis and monitoring of gonadotrophin producing metastases in the central nervous system. Cancer 38: 112-118
3. Brace KC (1968) The role of irradiation in the treatment of metastatic trophoblastic disease. Radiology 91: 540-544
4. Du Beshter B, Berkowitz RS, Goldstein DP and Bernstein MR Management of low risk metastatic gestational trophoblastic tumour. J Reprod Med 36: 36-39
5. Evans AC, Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez GC and Hammond CB (1995) Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol 59(2): 226-230
6. Fisher PM and Hancock BW (1997) Gestational trophoblastic diseases and their treatment. Cancer Treat Rev 23: 1-6
7. Newlands ES (1997) Investigation and treatment of patients with persistent Gestational Trophoblastic Disease and Gestational Trophoblastic: Tumors in the UK. In Gestational Trophoblastic Disease, Hancock BW, Newlands ES and Berkowitz RS (eds), pp. 173-190. Chapman & Hall: London
8. Roberts JP and Lurain JR (1996) Treatment of low risk metastatic gestational trophoblastic tumour with single-agent chemotherapy. Am J Obstet Gynecol 174: 1917-1924
9. Rustin GJS, Newlands ES, Begent RHJ, Dent J and Bagshawe KD (1989) Weekly alternating etoposide, methotrexate and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 7: 900-903
10. Shapiro WR, Young DR and Mehta BM (1975) Distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections. NEJM 293: 161-166
11. Sheridan E, Hancock BW, Smith SC, Dorreen MS, Neal FE, Pennington GW and Millar DR (1993) Gestational trophoblastic disease: experience of the Sheffield (United Kingdom) supraregional screening and treatment service. Int J Oncol 3: 149-155
12. Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez G and Hammond CB (1994). Five-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 54: 76-79
13. Weed JC and Hammond CB (1980) Cerebral metastatic choriocarcinoma: intensive therapy and prognosis. Obstet Gynecol 55: 89-94
14. Yordan EL, Schlaerth J, Gaddis O and Morrow CP (1987) Radiation therapy in the management of gestational choriocarcinoma metastatic to the central nervous system. Obstet Gynecol 69: 627-630